当前位置:
X-MOL 学术
›
Cancer Discov.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Gilead Buying Kite for $11.9 Billion
Cancer Discovery ( IF 28.2 ) Pub Date : 2017-09-06 , DOI: 10.1158/2159-8290.cd-nb2017-123 American Association for Cancer Research
中文翻译:
吉利德斥资119亿美元收购风筝
更新日期:2017-09-06
Cancer Discovery ( IF 28.2 ) Pub Date : 2017-09-06 , DOI: 10.1158/2159-8290.cd-nb2017-123 American Association for Cancer Research
Gilead Sciences will buy Kite Pharma—and its autologous CAR T-cell technology—for $11.9 billion. The acquisition will help Gilead build its oncology portfolio and boost its revenues.
中文翻译:
吉利德斥资119亿美元收购风筝
吉利德科学公司将以119亿美元的价格收购Kite Pharma及其自体CAR T细胞技术。此次收购将帮助吉利德建立其肿瘤学产品组合并增加收入。